Your browser doesn't support javascript.
loading
Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC.
Chen, Qiuqiang; Jia, Gang; Zhang, Xilin; Ma, Wenxue.
Afiliação
  • Chen Q; Key Laboratory for Translational Medicine, The First Affiliated Hospital, Huzhou University, Huzhou, Zhejiang, China.
  • Jia G; Department of Medical Oncology, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Zhang X; Key Laboratory for Translational Medicine, The First Affiliated Hospital, Huzhou University, Huzhou, Zhejiang, China.
  • Ma W; Department of Medicine, Moores Cancer Center, and Sanford Stem Cell Institute, University of California San Diego, La Jolla, CA, United States.
Front Immunol ; 15: 1376045, 2024.
Article em En | MEDLINE | ID: mdl-38357544
ABSTRACT
[This corrects the article DOI 10.3389/fimmu.2023.1332057.].
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article